Methionine Intake for Pregnancy

N/A

Waitlist Available

Led By Rajavel Elango, PhD

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women pregnant with a singleton pregnancy.

Women who are 11-20 or 31-40 weeks pregnant.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 hours

Awards & highlights

No Placebo-Only Group

Summary

This trial will test different levels of methionine to find out how much pregnant women need.

Who is the study for?

This trial is for healthy women aged 20-40, who are pregnant with one baby and either in their early (11-20 weeks) or late (31-38 weeks) stages of pregnancy. They should not have any pre-existing health conditions.

What is being tested?

The study is determining the necessary intake of methionine, an essential amino acid, during different stages of pregnancy using a safe and non-invasive method involving diet variation, stable isotopes, and breath collection.

What are the potential side effects?

Since this trial involves dietary adjustments rather than medication or invasive procedures, significant side effects are not anticipated. However, individual reactions to changes in diet may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am pregnant with one baby.

Select...

I am pregnant and either 11-20 or 31-40 weeks along.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

The rate of oxidation of 13C phenylalanine.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Methionine IntakeExperimental Treatment1 Intervention

Oral consumption of eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.

0 / 2Eligibility criteria met